Skip to content

IVL vs ELCA for Stent Underexpantsion (IVL-ELCA DRAGON)

Comparison of Intravascular Coronary Lithotripsy and Excimer Laser Coronary Atherectomy for Severe Stent Underexpansion: the Multicenter IVL- ELCA DRAGON Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06276114
Acronym
DRAGON
Enrollment
121
Registered
2024-02-23
Start date
2020-08-01
Completion date
2023-10-31
Last updated
2024-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Calcification, Excimer Laser-coronary Atherectomy, Intravascular Lithotripsy, Stent Occlusion, Stent Restenosis

Brief summary

The IVL- ELCA DRAGON Registry is a multicenter study that enrolled consecutive patients with stent underexpansion treated with IVL ora ELCA in high-volume PCI centers. The primary efficacy endpoint was device success (technical success with a final stent expansion ≥ 80%). Thirty days device-oriented composite endpoint (DOCE: cardiac death, target lesion revascularization, or target vessel myocardial infarction) was the secondary endpoint.

Interventions

DEVICEStent Underexpansion

Stent underexpansion was diagnosed as stent expansion of \<80% assessed with intravascular imaging.

Sponsors

Medical University of Silesia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Stent underexpansion as stent expansion of \<80% assessed with intravascular imaging (minimum in-stent lumen area divided by average reference lumen area x100%).

Design outcomes

Primary

MeasureTime frameDescription
The primary efficacy endpoint was device successDuring procedureTechnical success with a final stent expansion ≥80%.

Secondary

MeasureTime frameDescription
Device-oriented composite endpoint (DOCE)Thirty dayscardiac death, target lesion revascularization, or target vessel myocardial infarction

Countries

Italy, Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026